Literature DB >> 10812316

The standard of reporting of health-related quality of life in clinical cancer trials.

C W Lee1, K N Chi.   

Abstract

UNLABELLED: The standard of reporting of randomized controlled trials (RCTs) is important to the interpretation of outcomes such as health-related quality of life (HRQL). HRQL is used increasingly as an outcome in clinical cancer trials.
DESIGN: All 1997 issues of 36 selected journals were hand searched to identify original articles that included the term "quality of life" in the title, abstract, keywords or methods. Studies were included if they were RCTs and addressed cancer-related topics. A checklist to assess the adequacy of reporting of HRQL was developed based on a guideline previously published by an expert panel. Two unblinded reviewers applied the quality of life reporting (QLR) and CONSORT checklists, along with an instrument to assess the likelihood of bias to each selected RCT.
RESULTS: 72 articles were identified of which 20 were RCTs and cancer-related. For these 20 reports the median number of items in the QLR checklist that were adequately reported is 42% (range 15% to 85%). The median number of items in the CONSORT checklist that were adequately reported is 70% (range 47% to 95%). The mean score for the instrument to assess the likelihood for bias is 2.6 (95% CI 2. 08-3.12).
CONCLUSIONS: The current standard of reporting of HRQL needs to be improved. Major deficiencies that should be addressed are failure to provide a rationale for HRQL assessment and inadequate description of methodology. Development and application of structured formats for presentation of HRQL may help to improve the standard of reporting of HRQL in the literature.

Entities:  

Mesh:

Year:  2000        PMID: 10812316     DOI: 10.1016/s0895-4356(99)00221-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  24 in total

1.  Standards are needed for quality of life clinical trials.

Authors:  Andrew Bottomley; Fabio Efficace; Peter M Fayers
Journal:  BMJ       Date:  2002-05-11

Review 2.  Health-related quality of life and regulatory issues in the US and Canada.

Authors:  Judith Glennie
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 3.  Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.

Authors:  Michael Brundage; Brenda Bass; Judith Davidson; John Queenan; Andrea Bezjak; Jolie Ringash; Anna Wilkinson; Deb Feldman-Stewart
Journal:  Qual Life Res       Date:  2010-11-26       Impact factor: 4.147

Review 4.  Quality of life assessment in surgical oncology trials.

Authors:  Kerry Avery; Jane M Blazeby
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

5.  Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania.

Authors:  Jolanta Sumskiene; Linas Sumskas; Dalius Petrauskas; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

6.  Effectiveness and complications of anthracycline and taxane in the therapy of breast cancer: a meta-analysis.

Authors:  Qing-jing Feng; Feng Zhang; Xiao-yun Huang; Zhi-xiang Wu
Journal:  Pathol Oncol Res       Date:  2013-08-27       Impact factor: 3.201

7.  A knowledge translation challenge: clinical use of quality of life data from cancer clinical trials.

Authors:  Michael Brundage; Brenda Bass; Ringash Jolie; Kimberley Foley
Journal:  Qual Life Res       Date:  2011-01-29       Impact factor: 4.147

Review 8.  Individualizing cancer screening in older adults: a narrative review and framework for future research.

Authors:  Elizabeth Eckstrom; David H Feeny; Louise C Walter; Leslie A Perdue; Evelyn P Whitlock
Journal:  J Gen Intern Med       Date:  2012-09-28       Impact factor: 5.128

Review 9.  Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review.

Authors:  Despina G Contopoulos-Ioannidis; Anastasia Karvouni; Ioanna Kouri; John P A Ioannidis
Journal:  BMJ       Date:  2009-01-12

10.  Patient reported outcomes: looking beyond the label claim.

Authors:  Lynda C Doward; Ari Gnanasakthy; Mary G Baker
Journal:  Health Qual Life Outcomes       Date:  2010-08-20       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.